Education
About Us
Working with TipRanks
Follow Us
Arnold Hanish Insider Profile
4 Followers
Arnold Hanish, Director at Omeros, holds 5.00K shares in Decoy Therapeutics (Ticker: DCOY), holds 12.40K shares in Omeros (Ticker: OMER), holds 26.20K shares in Eli Lilly & Co (Ticker: LLY). Most recently, Arnold Hanish Sold ― shares of Decoy Therapeutics on Jan 02, 2026 for an estimated value of $17.01.
Profitable Transactions
2 out of 8 Profitable Transactions
Average Return
+0.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Arnold Hanish holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 12, 2020 - Feb 12, 2021
Return:+211.20%
The most profitable trade made by Arnold Hanish
Arnold Hanish's Trading History
Omeros
May 23, 2023
Director
Informative Sell
32.30K
$143.72K
Decoy Therapeutics
Jan 02, 2026
Director
Informative Sell
17.01
$3.29K
Eli Lilly & Co
Oct 29, 2012
CAO
Uninformative Sell
―
$26.29M
List of latest transactions for each holding click on a transaction to see Arnold Hanish's performance on stock
You May Also Like
Arnold Hanish insider profile FAQ
What is the percentage of profitable transactions made by Arnold Hanish?
The percentage of profitable transactions made by Arnold Hanish is 25%.
What is the average return per transaction made by Arnold Hanish?
The average return per transaction made by Arnold Hanish is 0.60%.
What stocks does Arnold Hanish hold?
Arnold Hanish holds: OMER, DCOY, LLY stocks.
What was Arnold Hanish’s latest transaction?
Arnold Hanish latest transaction was an Informative Sell of $17.01.
What was Arnold Hanish's most profitable transaction?
Arnold Hanish’s most profitable transaction was an Informative Buy of DCOY stock on February 12, 2020. The return on the trade was 211.20%.
What is Arnold Hanish's role in Omeros?
Arnold Hanish's role in Omeros is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.